FIELD: biotechnology.
SUBSTANCE: invention relates to biologically active peptide of sea anemone Metridium senile, having the following amino acid sequence H2N-Asnl-Ile2-Ile3-Val4-Gly5-Gly6-Cys7-Ile8-Lys9-Cys10-His11-Val12-Lys13-Asn14-Ala15-Ser16-Gly17-Arg18-Cys19-Val20-Arg21-Ile22-Val23-Gly24-Cys25-Gly26-Val27-Asp28-Lys29-Val30-Pro31-Asp32-Leu33-Phe34-Ser35-COOH. The peptide can be used as a medicament alone or in conjunction with other components to relieve pain conditions in humans and animals stipulated by participation of TRPA1 receptors, as well as for clarification of topology and molecular mechanisms of TRPA1 channels functioning, studying of TRPA1 channels distribution in living organisms, in test systems for detection and testing of new drugs against pain and/or inflammation, TRPA1 receptor agonists and antagonists, or for production of antibodies used for scientific and medical purposes.
EFFECT: increase of analgesic effect by inhibiting the functional activity of ion channel TRPA1.
10 dwg, 13 ex
Title | Year | Author | Number |
---|---|---|---|
ANALGESIC PEPTIDE FROM SEA ANEMONE URTICINA GREBELNYI | 2013 |
|
RU2521657C1 |
POLYPEPTIDE FROM SEA ANEMONE HETERACtis crispa, HAVING ANALGESIC ACTION | 2012 |
|
RU2475497C1 |
PEPTIDE MODULATOR OF PURINERGIC RECEPTORS | 2016 |
|
RU2650780C1 |
ACTINIA POLYPEPTIDE, POSSESSING ANALGESIC ACTION | 2009 |
|
RU2404245C1 |
PEPTIDE PURINOCEPTOR MODULATOR | 2010 |
|
RU2422459C1 |
ACTINIA POLYPEPTIDE HAVING ANALGETIC ACTION | 2008 |
|
RU2368621C1 |
AGENT WITH PROLONGED ANALGESIC ACTION AND MEDICINAL PRODUCT BASED THEREON | 2020 |
|
RU2755206C1 |
METHODS AND COMPOSITIONS FOR TREATING HYPERALGESIA | 2007 |
|
RU2430750C2 |
RECOMBINANT PLASMID DNA PSMT3_HCRG21 ENCODING A HYBRID PROTEIN SMT3-HCRG21, BACTERIAL STRAIN ESCHERICHIA COLI BL21(DE3)/PSMT3_HCRG21 - PRODUCER OF HCRG21 ANALGESIC PEPTIDE AND METHOD OF PRODUCING RECOMBINANT HCRG21 ANALGESIC PEPTIDE | 2022 |
|
RU2798545C1 |
POLYPEPTIDE FROM HETERACTIS MAGNIFICA SEA ANEMONE INHIBITING MAMMALIAN Α-AMYLASES AND ITS USE AS AN INHIBITOR OF MAMMALIAN Α-AMYLASES, AS WELL AS AGENTS FOR THE TREATMENT AND/OR PREVENTION OF POSTPRANDIAL HYPERGLYCEMIA, CORRECTION OF OVERWEIGHT AND OBESITY | 2022 |
|
RU2796823C1 |
Authors
Dates
2017-03-29—Published
2016-02-12—Filed